Tag: Protalix BioTherapeutics

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, Aug. 7, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsProtalix BioTherapeutics

Orezone to Commence Trading on the ASX Under Ticker “ORE”

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Hampton Financial Corporation Announces The Completion of A Non-Brokered Private Placement of Debentures

Tag: Protalix BioTherapeutics

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us